CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 200 enrolled
Drug / intervention
Administration of Red Cellbiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03407573
NCT03407573N/ACompleted
CompareCT.gov

The Impact of Restrictive Versus Liberal Transfusion Strategy on Cardiac Injury in Patients Undergoing Surgery for Fractured Neck Of Femur Study

NHS Lothian·interventional·Posted Jan 23, 2018·Updated Mar 11, 2020

In Brief

A clinical study evaluating Administration of Red Cell for Anemia and 3 related conditions. Completed, enrolled 200 participants across 1 site.

Detailed Summary

The investigator wishes to see if it is possible to undertake a study comparing blood transfusion at two different levels of anaemia to see which is best for patients. All patients that present to hospital with a broken hip will be able to take part in the study. If they become anaemic during their treatment they will be allocated to either be transfused when their blood count is less that 9 or less than 7. In all patients, we will measure heart damage with a blood test that is very sensitive. The investigator will also collect data on the incidence of heart attacks and other complications.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAnemia, Cardiac Event, Kidney Injury, Fractured Hip
CountriesUnited Kingdom
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedJan 23, 2018
Enrollment StartOct 1, 2017
Primary CompletionMar 1, 2019
Study CompletionJun 1, 2019
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 8.4 years ago

Interventions

Administration of Red Cellbiological

Transfusion of red cells dependent on haemoglobin level. Either transfused at haemoglobin of 7 or 9.